Endo International
Michael Randolph was appointed Global Head of Manufacturing Operations effective June 2022. Most recently, he served as Senior Vice President, Commercial Operations and General Manager, and was responsible for U.S. operations. He brings more than 30 years of global pharmaceutical manufacturing operations experience to the role as well as a passion for process improvement and quality. Prior to joining Endo in 2015, Mr. Randolph had roles of increasing responsibility at Fujifilm, Mylan, Teva and Baxter Healthcare. Mr. Randolph holds a Master of Science in Civil Engineering from Georgia Institute of Technology and a Bachelor of Science in Civil Engineering from North Carolina State University.
This person is not in any offices
Endo International
4 followers
Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceuticals company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization.